9-110800771-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_005592.4(MUSK):āc.2393A>Gā(p.Tyr798Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000116 in 1,614,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Y798Y) has been classified as Likely benign.
Frequency
Consequence
NM_005592.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MUSK | NM_005592.4 | c.2393A>G | p.Tyr798Cys | missense_variant | 15/15 | ENST00000374448.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MUSK | ENST00000374448.9 | c.2393A>G | p.Tyr798Cys | missense_variant | 15/15 | 5 | NM_005592.4 | P4 | |
MUSK | ENST00000416899.7 | c.2369A>G | p.Tyr790Cys | missense_variant | 14/14 | 5 | A1 | ||
MUSK | ENST00000189978.10 | c.2135A>G | p.Tyr712Cys | missense_variant | 14/14 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000963 AC: 24AN: 249162Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 135170
GnomAD4 exome AF: 0.0000821 AC: 120AN: 1461716Hom.: 0 Cov.: 32 AF XY: 0.0000825 AC XY: 60AN XY: 727142
GnomAD4 genome AF: 0.000440 AC: 67AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000457 AC XY: 34AN XY: 74472
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 01, 2019 | - - |
Fetal akinesia deformation sequence 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jun 30, 2021 | - - |
Congenital myasthenic syndrome 9 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Fetal akinesia deformation sequence 1;C4225368:Congenital myasthenic syndrome 9 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at